Pacira BioSciences, Inc. PCRX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s free cash flow margin?
- Pacira BioSciences, Inc. (PCRX) reported free cash flow margin of 18.1% in Q1 2026.
- How has Pacira BioSciences, Inc.'s free cash flow margin changed year-over-year?
- Pacira BioSciences, Inc.'s free cash flow margin decreased by 20.4% year-over-year, from 22.7% to 18.1%.
- What is the long-term trend for Pacira BioSciences, Inc.'s free cash flow margin?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s free cash flow margin has grown at a 15.6% compound annual growth rate (CAGR), from 9.1% to 18.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.